Valuation: RaySearch Laboratories AB

Market Cap 5.86B 591M 518M 490M 446M 835M 56.63B 841M 2.27B 28.93B 2.22B 2.17B 92.98B P/E 2026 *
21.8x
P/E 2027 * 17.5x
Enterprise Value 6.01B 606M 532M 503M 458M 857M 58.13B 864M 2.33B 29.7B 2.28B 2.23B 95.44B EV / Sales 2026 *
4.31x
EV / Sales 2027 * 3.6x
Free-Float
80.09%
Yield 2026 *
2.29%
Yield 2027 * 2.74%
1 day+1.14%
1 week-2.87%
Current month-5.14%
1 month-4.75%
3 months-18.29%
6 months-6.81%
Current year-24.55%
1 week 167.8
Extreme 167.8
174.3
1 month 167
Extreme 167
186.9
Current year 161
Extreme 161
237
1 year 161
Extreme 161
262
3 years 79.99
Extreme 79.9948
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%-2.87% - - 591M
+2.12%+7.87%-3.30%+40.77% 45.44B
-1.63%-5.05%-46.65%+101.22% 11.81B
+2.59%-1.45%-7.46%+118.04% 5.54B
+1.05%-3.11%+48.73% - 4.28B
-5.25%-11.61% - - 1.94B
+1.91%+4.44%+9.57%-26.15% 1.54B
+0.08%-1.95%-35.57% - 1.01B
-0.61%-3.19%+9.98%+150.00% 960M
-1.14%-5.77%+30.96%+41.32% 859M
Average +0.03%-2.20%+0.78%+70.87% 8.15B
Weighted average by Cap. +1.19%+3.42%-7.27%+58.08%

Financials

2026 *2027 *
Net sales 1.4B 141M 124M 117M 106M 199M 13.5B 201M 541M 6.89B 529M 517M 22.16B 1.63B 165M 144M 136M 124M 233M 15.77B 234M 632M 8.06B 618M 604M 25.89B
Net income 272M 27.43M 24.07M 22.73M 20.71M 38.78M 2.63B 39.05M 105M 1.34B 103M 101M 4.32B 338M 34.03M 29.86M 28.2M 25.7M 48.11M 3.26B 48.46M 131M 1.67B 128M 125M 5.36B
Net Debt 155M 15.63M 13.71M 12.95M 11.8M 22.1M 1.5B 22.25M 60.03M 765M 58.68M 57.41M 2.46B 7M 706K 619K 585K 533K 998K 67.65M 1.01M 2.71M 34.56M 2.65M 2.59M 111M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
26-09-25 SEK 173.40 +2.91% 8,509
26-09-24 SEK 168.50 -1.61% 9,765
26-09-23 SEK 171.25 +1.63% 7,384
26-09-22 SEK 168.50 -3.05% 1,919
26-09-21 SEK 173.80 -2.08% 1,261
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
174.30SEK
Average target price
297.50SEK
Spread / Average Target
+70.68%

Quarterly revenue - Rate of surprise